KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Accumulated Expenses (2017 - 2024)

Historic Accumulated Expenses for Elanco Animal Health (ELAN) over the last 8 years, with Q4 2024 value amounting to $177.0 million.

  • Elanco Animal Health's Accumulated Expenses rose 1273.89% to $177.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $177.0 million, marking a year-over-year increase of 1273.89%. This contributed to the annual value of $177.0 million for FY2024, which is 1273.89% up from last year.
  • As of Q4 2024, Elanco Animal Health's Accumulated Expenses stood at $177.0 million, which was up 1273.89% from $157.0 million recorded in Q4 2023.
  • In the past 5 years, Elanco Animal Health's Accumulated Expenses ranged from a high of $185.0 million in Q4 2021 and a low of $56.2 million during Q1 2020
  • In the last 5 years, Elanco Animal Health's Accumulated Expenses had a median value of $136.0 million in 2022 and averaged $128.6 million.
  • In the last 5 years, Elanco Animal Health's Accumulated Expenses skyrocketed by 11678.32% in 2021 and then tumbled by 2108.11% in 2022.
  • Over the past 5 years, Elanco Animal Health's Accumulated Expenses (Quarter) stood at $144.0 million in 2020, then rose by 28.47% to $185.0 million in 2021, then decreased by 21.08% to $146.0 million in 2022, then increased by 7.53% to $157.0 million in 2023, then rose by 12.74% to $177.0 million in 2024.
  • Its last three reported values are $177.0 million in Q4 2024, $157.0 million for Q4 2023, and $110.0 million during Q1 2023.